One of the notable advantages of lobaplatin is its improved safety profile compared to earlier platinum-based agents. It is associated with reduced nephrotoxicity and neurotoxicity, common side effects of cisplatin. This makes it a potentially safer option for patients who may be at higher risk for these adverse effects. Additionally, lobaplatin has shown effectiveness in cases where tumors have developed resistance to other platinum-based therapies.
